+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radioimmunotherapy"

From
From
From
Personalized Cancer Treatment Market Report 2025 - Product Thumbnail Image

Personalized Cancer Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Thumbnail Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • April 2025
  • 307 Pages
  • Global
From
Radiotheranostics Market Report 2025 - Product Thumbnail Image

Radiotheranostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nuclear Medicine Market Report 2025 - Product Thumbnail Image

Nuclear Medicine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Nuclear Medicine Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Nuclear Medicine Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
From
Radiopharmaceuticals Market Report and Forecast 2023-2031 - Product Thumbnail Image

Radiopharmaceuticals Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
From
Loading Indicator

Radioimmunotherapy (RIT) is a type of immunotherapy used to treat immune disorders. It combines the targeting ability of monoclonal antibodies with the cell-killing power of radiation. RIT works by attaching a radioactive isotope to an antibody that binds to a specific antigen on the surface of cancer cells. The radiation then kills the cancer cells, while leaving healthy cells unharmed. RIT is used to treat a variety of immune disorders, including lymphoma, leukemia, and multiple myeloma. It is also used to treat some solid tumors, such as neuroblastoma and melanoma. RIT is a relatively new form of treatment, and is still being studied for its effectiveness and safety. It is often used in combination with other treatments, such as chemotherapy and radiation therapy. Some companies in the RIT market include Advanced Accelerator Applications, Immunomedics, and Endocyte. Show Less Read more